Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19
Clinical trial NCT04550325 · COMPLETED
Trial details
- NCT number
- NCT04550325
- Sponsor
- Kamada, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2020-11-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.